1. Bone health during endocrine therapy for cancer. Issue 11 (November 2018) Authors: Rachner, Tilman D; Coleman, Robert; Hadji, Peyman; Hofbauer, Lorenz C Journal: Lancet Issue: Volume 6:Issue 11(2018) Page Start: 901 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glycosaminoglycans and their sulfate derivatives differentially regulate the viability and gene expression of osteocyte-like cell lines. (September 2014) Authors: Tsourdi, Elena; Salbach-Hirsch, Juliane; Rauner, Martina; Rachner, Tilman D; Möller, Stephanie; Schnabelrauch, Matthias; Scharnweber, Dieter; Hofbauer, Lorenz C Journal: Journal of bioactive and compatible polymers Issue: Volume 29:Number 5(2014:Sep.) Page Start: 474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Individualized Bone‐Protective Management in Long‐Term Cancer Survivors With Bone Metastases. (24th June 2021) Authors: Rachner, Tilman D; Coleman, Robert; Hadji, Peyman; Hofbauer, Lorenz C Journal: Journal of bone and mineral research Issue: Volume 36:Number 10(2021) Page Start: 1906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term bone health in childhood cancer survivors: underappreciated and undertreated?. Issue 1 (January 2023) Authors: Link-Rachner, Cornelia S; Rachner, Tilman D Journal: Lancet Issue: Volume 11:Issue 1(2023) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. More DATA to guide sequential osteoporosis therapy. Issue 9999 (19th September 2015) Authors: Hofbauer, Lorenz C; Rachner, Tilman D Journal: Lancet Issue: Volume 386:Issue 9999(2015) Page Start: 1116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Novel therapies in osteoporosis: PTH-related peptide analogs and inhibitors of sclerostin. (February 2019) Authors: Rachner, Tilman D; Hofbauer, Lorenz C; Göbel, Andy; Tsourdi, Elena Journal: Journal of molecular endocrinology Issue: Volume 62:Number 2(2019) Page Start: R145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. WNT5A and Its Receptors in the Bone‐Cancer Dialogue. (August 2016) Authors: Thiele, Stefanie; Rachner, Tilman D; Rauner, Martina; Hofbauer, Lorenz C Journal: Journal of bone and mineral research Issue: Volume 31:Number 8(2016:Aug.) Page Start: 1488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. WNT5A Has Anti‐Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo. (16th February 2015) Authors: Thiele, Stefanie; Göbel, Andy; Rachner, Tilman D; Fuessel, Susanne; Froehner, Michael; Muders, Michael H; Baretton, Gustavo B; Bernhardt, Ricardo; Jakob, Franz; Glüer, Claus C; Bornhäuser, Martin; Rauner, Martina; Hofbauer, Lorenz C Journal: Journal of bone and mineral research Issue: Volume 30:Number 3(2015:Mar.) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. WNT5A Has Anti‐Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo. (March 2015) Authors: Thiele, Stefanie; Göbel, Andy; Rachner, Tilman D; Fuessel, Susanne; Froehner, Michael; Muders, Michael H; Baretton, Gustavo B; Bernhardt, Ricardo; Jakob, Franz; Glüer, Claus C; Bornhäuser, Martin; Rauner, Martina; Hofbauer, Lorenz C Journal: Journal of bone and mineral research Issue: Volume 30:Number 3(2015:Mar.) Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗